Request for connections in early-stage oncology investing. I serve as fractional CFO to a preclinical oncology therapeutics company in the Seattle area. Novel target class, with a founding team whose prior work includes an FDA-approved drug and a clinical-stage program. I am building a map of investors currently active in seed-stage preclinical therapeutics. Angels, syndicates, small life science funds, and disease foundations that write early checks in oncology. If you know individuals or groups worth knowing in this space, I would welcome the names. Glad to reciprocate on anything finance or CFO related. Brandon McNally Managing Partner, Northward Partners